Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients with sepsis and septic shock

doi:10.5492/wjccm.v10.i1.22

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8334)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

500

WORD

210

HTML

4226

Figures (1-3)

307

Tables (1-5)

291

Sum=5534

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

462

Download

841

Sum=1303

Publishing Process of This Article

Item

Count

Browse

430

Download

1067

Sum=1497

Jan 9, 2021 (publication date) through Sep 20, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Crit Care Med. Jan 9, 2021; 10(1): 22-34
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.22

Table 4 Cytokine assay results for survivors

Cytokine	Pre CytoSorb^®therapy, mean ± SD	Post CytoSorb^®therapy, mean ± SD	Percentage change	P value
IL1, pg/mL	10.74 ± 9.70	9.54 ± 9.66	11.11	0.5580
IL6, pg/mL	889.15 ± 1307.43	423.69 ± 1105.55	52.34	0.0792

IL: Interleukin.

Citation: Paul R, Sathe P, Kumar RS, Prasad S, Aleem M, Sakhalvalkar P. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb^®) in patients with sepsis and septic shock. World J Crit Care Med 2021; 10(1): 22-34
URL: https://www.wjgnet.com/2220-3141/full/v10/i1/22.htm
DOI: https://dx.doi.org/10.5492/wjccm.v10.i1.22